65532 results
-
List item
Human medicine European public assessment report (EPAR): Ocrevus (updated)
ocrelizumab, Multiple Sclerosis
Date of authorisation: 08/01/2018,
, Revision: 9, Authorised, Last updated: 22/01/2021
-
List item
EMA’s governance during COVID-19 pandemic (updated)
Last updated: 22/01/2021 -
List item
COVID-19: latest updates (updated)
Last updated: 22/01/2021 -
List item
Paediatric Committee (PDCO): 8-11 December 2020 (updated)
Virtual meeting, from 08/12/2020 to 11/12/2020, Last updated: 22/01/2021 -
List item
EU big data stakeholder virtual forum (updated)
Virtual meeting, 15/12/2020, Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Zerbaxa (updated)
ceftolozane sulfate, tazobactam sodium, Bacterial Infections
Date of authorisation: 18/09/2015, Revision: 13, Authorised, Last updated: 22/01/2021 -
List item
Big data (updated)
Last updated: 22/01/2021 -
List item
Treatments and vaccines for COVID-19: post-authorisation (updated)
Last updated: 22/01/2021 -
List item
Human medicine European public assessment report (EPAR): Symkevi (updated)
tezacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 31/10/2018,, 
, Revision: 7, Authorised, Last updated: 22/01/2021
-
List item
Human medicine European public assessment report (EPAR): Dupixent (updated)
dupilumab, Dermatitis, Atopic
Date of authorisation: 27/09/2017,, Revision: 9, Authorised, Last updated: 22/01/2021